Doctors who perform this procedure

Edit search filters
close

Narrow your search

  1. There are no doctors whose last name begins with the letter A
  2. There are no doctors whose last name begins with the letter B
  3. There are no doctors whose last name begins with the letter C
  4. Find a doctor whose last name begins with the letter D
  5. There are no doctors whose last name begins with the letter E
  6. There are no doctors whose last name begins with the letter F
  7. There are no doctors whose last name begins with the letter G
  8. There are no doctors whose last name begins with the letter H
  9. There are no doctors whose last name begins with the letter I
  10. There are no doctors whose last name begins with the letter J
  11. There are no doctors whose last name begins with the letter K
  12. There are no doctors whose last name begins with the letter L
  13. Find a doctor whose last name begins with the letter M
  14. There are no doctors whose last name begins with the letter N
  15. There are no doctors whose last name begins with the letter O
  16. There are no doctors whose last name begins with the letter P
  17. There are no doctors whose last name begins with the letter Q
  18. There are no doctors whose last name begins with the letter R
  19. Find a doctor whose last name begins with the letter S
  20. There are no doctors whose last name begins with the letter T
  21. There are no doctors whose last name begins with the letter U
  22. There are no doctors whose last name begins with the letter V
  23. There are no doctors whose last name begins with the letter W
  24. There are no doctors whose last name begins with the letter X
  25. There are no doctors whose last name begins with the letter Y
  26. There are no doctors whose last name begins with the letter Z
Reset all filters

Displaying 1-3 out of 3 doctors available

  1. David R. Deyle, M.D.

    David R. Deyle, M.D.

    1. Internist
    2. Medical Geneticist
    1. Rochester, MN
    Areas of focus:

    Gene therapy, Osteogenesis imperfecta, Skeletal dysplasia

  2. John C. Morris, III, M.D.

    John C. Morris, III, M.D.

    1. Internist
    2. Endocrinologist
    1. Rochester, MN
    Areas of focus:

    Gene therapy, Thyroid cancer, Hypothyroidism, Hyperthyroidism, Graves' disease

  3. Brittni A. Scruggs, M.D., Ph.D.

    Brittni A. Scruggs, M.D., Ph.D.

    1. Ophthalmologist
    1. Rochester, MN
    Areas of focus:

    Photodynamic therapy, Gene therapy, Optical coherence tomography, Genetic counseling, Visual electrophysiology, Retinal... surgery, Lens replacement surgery, Vitrectomy, Anti-VEGF injection therapy, Retinal angiogram, Laser eye surgery, Retinal exam, Eye injection, Scleral buckling, Diabetic retinopathy, Retinal degeneration, Retinal detachment, Retinal disease, Stickler syndrome, Retinitis pigmentosa, Eye injury, Eye floaters, Macular degeneration, Retinal vein occlusion, Epiretinal membrane, Macular hole, Retinal artery occlusion, Pediatric trauma, Genetic eye disease, Eye infection, Vitreous detachment, Retinopathy of prematurity, Vitreous hemorrhage, Inherited retinal disorders, Best vitelliform macular dystrophy, Macular edema, Stargardt's disease

Dec. 29, 2017
  1. Gene therapy. Genetics Home Reference. http://ghr.nlm.nih.gov/handbook/therapy. Accessed July 21, 2016.
  2. What is gene therapy? National Cancer Institute. http://cancer.gov/ about-cancer/treatment/types/immunotherapy/bio-therapies-fact-sheet#q8. Accessed July 22, 2016.
  3. Chuah M, et al. Recent progress in gene therapy for hemophilia. Human Gene Therapy. 2012;23;557.
  4. FAQs. American Society of Gene & Cell Therapy. http://www.asgct.org/general-public/educational-resources/faqs. Accessed July 22, 2016.
  5. Cicalese M, et al. Clinical applications of gene therapy for primary immunodeficiencies. Human Gene Therapy. 2015;26:210.
  6. Ghazi N, et al. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: Results of a phase I trial. Human Genetics. 2016;135;327.
  7. Schubert M, et al. Chimeric antigen receptor T cell therapy targeting CD19 positive leukemia and lymphoma in the context of stem cell transplantation. Human Gene Therapy. In press. Accessed Aug. 13, 2016.
  8. Russell SJ (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 29, 2016.